News

Understanding Recent Trends in Eli Lilly Options Activity

Understanding Recent Trends in Eli Lilly Options Activity

Investors Eyeing Eli Lilly's Options: Key Insights

In recent trading activity, significant bearish sentiment has emerged surrounding Eli Lilly (LLY). This trend is noteworthy, especially for both institutional and retail investors looking to understand market dynamics.

Recent Trading Activity Analysis

Today's analysis of options trades highlights a stark contrast in attitudes among investors. With a meticulous examination of available public options history, a total of 45 unusual options trades for Eli Lilly caught our attention. These trades indicate that major investors might be anticipating notable developments ahead.

To further dissect this sentiment, the numbers indicate a division among these big-money traders. An intriguing mix has emerged, with 35% displaying bullish tendencies while approximately 40% are bearish. This divergence reflects speculative strategies and could indicate differing opinions on the company's future.

Current Price Movements and Projections

What Are the Price Expectations?

Within the uncovered trades, 16 contracts were puts, collectively valued at $787,657, while 29 calls totaled approximately $1,433,279. When examining volume and open interest trends, analysts believe the price targets for Eli Lilly may fluctuate between the remarkable range of $440.00 and $1340.00 over the past quarter. Such estimations signal a proactive approach to volatility and potential price movements.

Volume & Open Interest Insights

For seasoned options traders, understanding volume and open interest is crucial. These indicators improve comprehension of investor intent and the overall liquidity of Eli Lilly's options market. The data from the previous month illustrates both calls and puts linked to Eli Lilly, providing a clear picture of how traders are positioning themselves within the indicated strike price spectrum.

In-Depth Look at Recent Trends

Over the last 30 days, substantial options activity has unfolded for Eli Lilly. Below is a summary of key trades observed during this period:

Highlighted Options Trades

While reviewing the considerable volume of options trades, we've tabulated significant findings:

Significant Options Trades Detected:

1. **Symbol:** LLY, **Type:** CALL, **Sentiment:** BEARISH, **Exp. Date:** 01/17/25, **Price:** $73.00, **Total Trade Price:** $182.5K

2. **Symbol:** LLY, **Type:** PUT, **Sentiment:** BULLISH, **Exp. Date:** 10/25/24, **Price:** $7.60, **Total Trade Price:** $152.0K

3. **Symbol:** LLY, **Type:** PUT, **Sentiment:** BULLISH, **Exp. Date:** 02/21/25, **Price:** $25.90, **Total Trade Price:** $129.5K

4. **Symbol:** LLY, **Type:** CALL, **Sentiment:** BEARISH, **Exp. Date:** 12/20/24, **Price:** $54.25, **Total Trade Price:** $81.3K

5. **Symbol:** LLY, **Type:** CALL, **Sentiment:** BULLISH, **Exp. Date:** 01/17/25, **Price:** $153.63, **Total Trade Price:** $76.8K

About Eli Lilly

Eli Lilly is renowned for its cutting-edge advancements in pharmaceuticals, focusing on areas such as neuroscience, cardiometabolic disorders, oncology, and immunology. The company's impressive lineup includes treatments like Verzenio for cancer and Mounjaro for weight management.

Current Position of Eli Lilly

In recent trading sessions, Eli Lilly observed a volume of 838,270 shares, with stock price adjusting marginally by 0.08%, standing at $916.36. Current RSI indicators indicate a neutral market, revealing balanced conditions between overbought and oversold scenarios.

Analysts anticipate the next earnings report from Eli Lilly within a fortnight, which adds excitement and intrigue to the existing trading landscape.

Market Expert Perspectives on Eli Lilly

In the assessments released over the past month, three market experts have issued ratings on Eli Lilly. Their collective average target price estimates hover around $1052.67, with one analyst from Bernstein having recently downgraded its rating while establishing a target of $1100. Additionally, Deutsche Bank adjusted its forecast to a price target of $1025, and Truist Securities remains firm with a Buy recommendation, targeting $1033.

While options present a compelling avenue for profit, they come with inherent risks. Savvy traders often balance risk and reward by engaging in daily analysis and trading strategies. Education remains fundamental in navigating the options market.

Frequently Asked Questions

What is the recent trend in Eli Lilly's options trades?

Recent trading shows a mix of bullish and bearish sentiment among investors, indicating potential volatility for Eli Lilly (LLY).

How do volume and open interest affect options trading in Eli Lilly?

Volume and open interest serve as indicators of market liquidity and investor interest, helping traders assess the positioning of the stock.

What are the projected price targets for Eli Lilly?

Price projections for LLY vary, with estimates ranging from $440.00 to $1340.00 based on recent options activity.

What feedback have market analysts provided on Eli Lilly?

Market analysts are generally optimistic, with target prices around $1052.67, with various ratings indicating confidence in LLY's potential.

Where can I find real-time updates on Eli Lilly options trades?

For real-time updates and alerts on Eli Lilly options trades, consider using financial tools that specialize in options tracking and alerts.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 179

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Matthew Callstrom Named CEO: Mayo Clinic's Next Era

Updated Category News Views 215

Leadership Change at Mayo Clinic: A Turning Point The Mayo Clinic, a titan in healthcare lands, is on the cusp of a major leadership switch-up. As the trustees hand the reins to Dr. Matthew R. Callstrom, they're banking on a rich blend of experience and visionary thinking to steer their ship. We're looking at what this change might spell for Mayo's storied mission. Who is...

Continue Reading
Fly-E Faces Revenue Drop Amid Retail Restructuring

Updated Category News Views 260

Downturn Despite Strategic Restructuring Today, we're diving into Fly-E Group, Inc. (NASDAQ:FLYE) and the latest shakeup in their financials—spoiler alert, it's riding a downward slope. Quarter two of fiscal 2027 didn't exactly shine a light on profitability. Net revenues slid, dropping to $2.6 million this quarter, down from $3.9 million the previous year. Tack that up...

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 122

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
Citigroup, Scotia Aid TSTT in $500M Note Offering

Updated Category News Views 201

Kicking off with a banger that’s got financial water coolers buzzing, Greenberg Traurig just pulled a rabbit out of the hat helping Citigroup and Scotia Capital orchestrate a chunky near $500 million dual-currency notes deal for Telecommunications Services of Trinidad and Tobago Limited (TSTT). Now, this isn’t your run-of-the-mill market maneuver. We're seeing a...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 108

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Thanksgiving in Outer Banks: Unique Traditions Await

Updated Category News Views 115

Thanksgiving Plans Off the Beaten Path Thanksgiving in the Outer Banks isn't just another holiday; it's a whole different ball game. Imagine trading in the usual family couch-potato marathon for a beachside gathering, where the sand replaces the snow, and coastal seafood joins the turkey on your dinner table. If you've been teetering on the edge of making plans, this...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 104

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading

Top 5 Most Recently Viewed Articles

The Brattle Group Enhances Services with New Principal

Updated Category News Views 168

The Brattle Group Enhances Services with New Principal The Brattle Group is pleased to announce the addition of Hans Weemaes as a Principal in its Financial Services & Markets and Regulatory Investigations & Enforcement practices. With an impressive background as a former economist for a federal treasury, Mr. Weemaes carries over 20 years of extensive experience in...

Continue Reading
Lumen and AWS Unite to Advance Generative AI Through Networks

Updated Category News Views 263

Lumen and AWS Join Forces in Generative AI Development Lumen Technologies (NYSE: LUMN) has announced a strategic collaboration with Amazon Web Services (AWS), an Amazon.com company (NASDAQ: AMZN), aiming to enhance network operations and delivery capabilities. This partnership is set against the backdrop of expanding AI-driven services that demand efficient and robust...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 46

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Modernization: Strengthening Ties Between China and Africa

Updated Category News Views 64

Modernization: Strengthening Ties Between China and Africa Recently, China Everything released an engaging short video titled "A shared path to modernization." This video highlights the successful collaboration between China and Africa, showcasing the strong friendship that has developed between the people of these two regions. The Unity of Aspirations As the largest...

Continue Reading
Okeanis Eco Tankers Announces Dividend Details for Shareholders

Updated Category News Views 129

Okeanis Eco Tankers Declares Dividend for Common Shares Okeanis Eco Tankers Corp. (NYSE: ECO / OSE: OET) has announced a significant dividend for its shareholders. The board of directors has officially declared a dividend on its common shares, representing a fruitful opportunity for investors as they participate in the company's success. This dividend is a reflection of...

Continue Reading